iSpecimen Inc. – NASDAQ:ISPC
Founder-led company
iSpecimen stock price today
$1.09
-1.72
-61.21%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
iSpecimen stock price monthly change
+812.93%
month
iSpecimen stock price quarterly change
+812.93%
quarter
iSpecimen stock price yearly change
+467.68%
year
iSpecimen key metrics
Market Cap | 2.75M |
Enterprise value | N/A |
P/E | -1.1 |
EV/Sales | -0.40 |
EV/EBITDA | 0.46 |
Price/Sales | 1.04 |
Price/Book | 0.53 |
PEG ratio | -0.02 |
EPS | -1.28 |
Revenue | 9.26M |
EBITDA | -9.78M |
Income | -11.56M |
Revenue Q/Q | -22.37% |
Revenue Y/Y | -14.45% |
Profit margin | -98.5% |
Oper. margin | -97.92% |
Gross margin | 54.27% |
EBIT margin | -97.92% |
EBITDA margin | -105.59% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeiSpecimen stock price history
iSpecimen stock forecast
iSpecimen financial statements
| Jun 2023 | 1.62M | -3.48M | -214.36% |
|---|---|---|---|
| Sep 2023 | 2.77M | -2.11M | -76% |
| Dec 2023 | 2.57M | -3.07M | -119.33% |
| Mar 2024 | 2.28M | -2.90M | -126.73% |
| 2025 | 12.70M | -13.53M | -106.57% |
|---|---|---|---|
| 2026 | 14.60M | 0 |
Analysts Price target
Financials & Ratios estimates
| 2024-03-13 | -0.24 | -0.34 |
|---|---|---|
| 2024-05-07 | -0.27 | -0.32 |
| Jun 2023 | 17570345 | 2.85M | 16.28% |
|---|---|---|---|
| Sep 2023 | 16295096 | 3.58M | 22.03% |
| Dec 2023 | 15819137 | 6.07M | 38.42% |
| Mar 2024 | 12513901 | 5.70M | 45.55% |
| Jun 2023 | -1.69M | -67.96K | 3.15K |
|---|---|---|---|
| Sep 2023 | -1.63M | 2.35M | 0 |
| Dec 2023 | 345.14K | -723.04K | 0 |
| Mar 2024 | -2.07M | 1.93M | -118.85K |
iSpecimen alternative data
| Aug 2023 | 75 |
|---|---|
| Sep 2023 | 75 |
| Oct 2023 | 75 |
| Nov 2023 | 75 |
| Dec 2023 | 75 |
| Jan 2024 | 75 |
| Feb 2024 | 75 |
| Mar 2024 | 53 |
| Apr 2024 | 53 |
| May 2024 | 53 |
| Jun 2024 | 53 |
| Jul 2024 | 53 |
iSpecimen other data
2.93%
-2.43%
of ISPC is owned by hedge funds
256.91K
-218.64K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 4400 | 0 |
| Sep 2023 | 18000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | BIELAK BENJAMIN officer: Chief Info Officer & S.. | Common Stock | 18,000 | $0.72 | $12,960 | ||
Purchase | CURLEY TRACY director, officer.. | Common Stock | 4,400 | $1.25 | $5,500 | ||
Option | MULLAN JILL director | Option | 66,637 | N/A | N/A | ||
Option | MULLAN JILL director | Common Stock | 66,637 | $1 | $66,637 | ||
Option | IANELLI CHRISTOPHER director, officer.. | Option | 48,106 | $1 | $48,106 | ||
Option | IANELLI CHRISTOPHER director, officer.. | Option | 3,099 | $1 | $3,099 | ||
Option | IANELLI CHRISTOPHER director, officer.. | Common Stock | 48,106 | $1 | $48,106 | ||
Option | MULLAN JILL director, officer.. | Option | 3,099 | $1 | $3,099 | ||
Option | MULLAN JILL director, officer.. | Option | 19,296 | $1 | $19,296 | ||
Option | IANELLI CHRISTOPHER director, officer.. | Common Stock | 3,099 | $1 | $3,099 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 14 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 3 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 5 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Ms. Tracy Wilson Curley (1961) Chief Financial Officer & Treasurer | $253,440 |
| Dr. Christopher J. Ianelli M.D., Ph.D. (1967) Founder, Pres, Chief Executive Officer & Director | $250,000 |
| Ms. Jill Mullan (1965) Chief Operating Officer, Treasurer, Sec. & Director | $230,000 |
Mr. Benjamin Bielak (1969) Chief Information Officer | $220,000 |
-
What's the price of iSpecimen stock today?
One share of iSpecimen stock can currently be purchased for approximately $1.09.
-
When is iSpecimen's next earnings date?
Unfortunately, iSpecimen's (ISPC) next earnings date is currently unknown.
-
Does iSpecimen pay dividends?
No, iSpecimen does not pay dividends.
-
How much money does iSpecimen make?
iSpecimen has a market capitalization of 2.75M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.56% to 9.93M US dollars. iSpecimen made a loss 11.1M US dollars in net income (profit) last year or -$0.32 on an earnings per share basis.
-
What is iSpecimen's stock symbol?
iSpecimen Inc. is traded on the NASDAQ under the ticker symbol "ISPC".
-
What is iSpecimen's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of iSpecimen?
Shares of iSpecimen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are iSpecimen's key executives?
iSpecimen's management team includes the following people:
- Ms. Tracy Wilson Curley Chief Financial Officer & Treasurer(age: 64, pay: $253,440)
- Dr. Christopher J. Ianelli M.D., Ph.D. Founder, Pres, Chief Executive Officer & Director(age: 58, pay: $250,000)
- Ms. Jill Mullan Chief Operating Officer, Treasurer, Sec. & Director(age: 60, pay: $230,000)
- Mr. Benjamin Bielak Chief Information Officer(age: 56, pay: $220,000)
-
Is iSpecimen founder-led company?
Yes, iSpecimen is a company led by its founder Dr. Christopher J. Ianelli M.D., Ph.D..
-
How many employees does iSpecimen have?
As Jul 2024, iSpecimen employs 53 workers.
-
When iSpecimen went public?
iSpecimen Inc. is publicly traded company for more then 4 years since IPO on 17 Jun 2021.
-
What is iSpecimen's official website?
The official website for iSpecimen is ispecimen.com.
-
Where are iSpecimen's headquarters?
iSpecimen is headquartered at 450 Bedford Street, Lexington, MA.
-
How can i contact iSpecimen?
iSpecimen's mailing address is 450 Bedford Street, Lexington, MA and company can be reached via phone at +7 813016700.
iSpecimen company profile:
iSpecimen Inc.
ispecimen.comExchange:
NASDAQ
Full time employees:
53
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
450 Bedford Street
Lexington, MA 02420
Lexington, MA 02420
CIK: 0001558569
ISIN: US45032V1089
CUSIP: 45032V108
